Tooth Extraction

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Xenograft bone substituteN/A1 trial
Active Trials
NCT02844569Completed24Est. Feb 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Geistlich PharmaXenograft bone substitute

Clinical Trials (1)

Total enrollment: 24 patients across 1 trials

NCT02844569Geistlich PharmaXenograft bone substitute

A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction

Start: Jul 2016Est. completion: Feb 201824 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space